TABLE 2.
Recommended Follow-up Period (days) on the Basis of Clinical Risk Index Score TSB and TcB Risk Group Measurements
| Clinical Risk Index Score |
TSB or TcB Risk Group | |||
|---|---|---|---|---|
| Low | Low-Intermediate | High-Intermediate | High | |
| ≥15 | 1–2 | 1 | 1 | 1 |
| 10–14 | 1–3 | 1–2 | 1 | 1 |
| 5–9 | a | 1–3 | 1–2 | 1 |
| <5 | a | a | 1–3 | 1 |
TSB levels were recommended if TcB values were ≥15 mg/dL or within 3 mg/dL of the AAP phototherapy. Bilirubin values were plotted on the nomogram described by Bhutani et al6 to determine risk group.
a
Very low risk of significant jaundice, but follow-up evaluation for other reasons may be required.